JP2022525651A5 - - Google Patents
Info
- Publication number
- JP2022525651A5 JP2022525651A5 JP2021556400A JP2021556400A JP2022525651A5 JP 2022525651 A5 JP2022525651 A5 JP 2022525651A5 JP 2021556400 A JP2021556400 A JP 2021556400A JP 2021556400 A JP2021556400 A JP 2021556400A JP 2022525651 A5 JP2022525651 A5 JP 2022525651A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- gene
- genetically modified
- hiv
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024163218A JP2024175115A (ja) | 2019-03-19 | 2024-09-20 | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820387P | 2019-03-19 | 2019-03-19 | |
| US62/820,387 | 2019-03-19 | ||
| PCT/US2020/023117 WO2020190925A1 (en) | 2019-03-19 | 2020-03-17 | Methods and compositions for engineering cd4-deficient car t cells and anti-cd4 car t cells and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163218A Division JP2024175115A (ja) | 2019-03-19 | 2024-09-20 | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525651A JP2022525651A (ja) | 2022-05-18 |
| JP2022525651A5 true JP2022525651A5 (https=) | 2024-01-30 |
Family
ID=72519342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556400A Pending JP2022525651A (ja) | 2019-03-19 | 2020-03-17 | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 |
| JP2024163218A Pending JP2024175115A (ja) | 2019-03-19 | 2024-09-20 | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024163218A Pending JP2024175115A (ja) | 2019-03-19 | 2024-09-20 | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220054549A1 (https=) |
| EP (1) | EP3941486A4 (https=) |
| JP (2) | JP2022525651A (https=) |
| WO (1) | WO2020190925A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4458378A4 (en) * | 2021-12-30 | 2025-07-09 | Chongqing Prec Biotech Co Ltd | TECHNIQUE FOR PREPARING A UNIVERSAL CAR-T CELL, AND APPLICATION OF A UNIVERSAL CAR-T CELL |
| CN116410932A (zh) * | 2021-12-30 | 2023-07-11 | 重庆精准生物技术有限公司 | 一种通用型car-t细胞的制备方法及其应用 |
| CN116410931A (zh) * | 2021-12-30 | 2023-07-11 | 重庆精准生物技术有限公司 | 一种通用型car-t细胞的制备技术及其应用 |
| WO2026032970A1 (en) * | 2024-08-07 | 2026-02-12 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Cd4-specific chimeric antigen receptor and methods and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710169B2 (en) * | 1987-10-02 | 2004-03-23 | Genentech, Inc. | Adheson variants |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| WO2017044776A1 (en) * | 2015-09-10 | 2017-03-16 | Texas Tech University System | Single-guide rna (sgrna) with improved knockout efficiency |
| WO2019106522A1 (en) * | 2017-11-28 | 2019-06-06 | Novartis Ag | Pooled crispr/cas9 screening in primary cells using guide swap technology |
-
2020
- 2020-03-17 US US17/435,535 patent/US20220054549A1/en active Pending
- 2020-03-17 JP JP2021556400A patent/JP2022525651A/ja active Pending
- 2020-03-17 EP EP20774852.6A patent/EP3941486A4/en active Pending
- 2020-03-17 WO PCT/US2020/023117 patent/WO2020190925A1/en not_active Ceased
-
2024
- 2024-09-20 JP JP2024163218A patent/JP2024175115A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525651A5 (https=) | ||
| AU2022271376B9 (en) | CRISPR/CAS-related methods and compositions for treating herpes simplex virus | |
| EP4176048B1 (en) | Genetically engineered t cells with regnase-1 and/or tgfbrii disruption have improved functionality and persistence | |
| JP7252328B2 (ja) | Ｒｎａを編集する方法および組成物 | |
| JP6929791B2 (ja) | エピゲノム編集のための組成物および方法 | |
| JP7553440B2 (ja) | 抗ｃｄ３３免疫細胞癌療法 | |
| JP2023055884A5 (https=) | ||
| Dabiri et al. | Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies | |
| JP2024097924A (ja) | 抗ｐｔｋ７免疫細胞癌療法 | |
| JP2016520319A5 (https=) | ||
| JP2021518102A5 (https=) | ||
| JP2021518162A5 (https=) | ||
| JP7471289B2 (ja) | 抗ｌｉｖ１免疫細胞癌療法 | |
| RU2019133280A (ru) | Композиции и способы для иммуноонкологии | |
| JP2022519595A5 (https=) | ||
| JP2017513520A (ja) | メトトレキサートによる選択と組み合わせたＳｌｅｅｐｉｎｇ Ｂｅａｕｔｙトランスポゾンによる遺伝子改変Ｔ細胞の製造 | |
| JP2022521787A (ja) | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 | |
| US20220145333A1 (en) | Improved process for integration of dna constructs using rna-guided endonucleases | |
| JP2021502077A5 (https=) | ||
| JP2024511131A5 (https=) | ||
| JP2024175115A (ja) | Ｃｄ４欠損ｃａｒ ｔ細胞および抗ｃｄ４ ｃａｒ ｔ細胞を作製するための方法および組成物ならびにその使用 | |
| KR102264115B1 (ko) | 무-운반체 다중 CRISPR/Cas 9 유전자 편집 복합체 및 그의 용도 | |
| CN118871583A (zh) | 修饰的基于crispr的基因编辑系统及其使用方法 | |
| JP2020513849A5 (https=) | ||
| US11053503B2 (en) | Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition |